AU2021104943A4 - Intelligent circuit enable covid-19 detection framework using iot - Google Patents
Intelligent circuit enable covid-19 detection framework using iot Download PDFInfo
- Publication number
- AU2021104943A4 AU2021104943A4 AU2021104943A AU2021104943A AU2021104943A4 AU 2021104943 A4 AU2021104943 A4 AU 2021104943A4 AU 2021104943 A AU2021104943 A AU 2021104943A AU 2021104943 A AU2021104943 A AU 2021104943A AU 2021104943 A4 AU2021104943 A4 AU 2021104943A4
- Authority
- AU
- Australia
- Prior art keywords
- covid
- iot
- intelligent circuit
- circuit enable
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 208000025721 COVID-19 Diseases 0.000 title claims abstract description 77
- 238000001514 detection method Methods 0.000 title claims abstract description 49
- 238000012545 processing Methods 0.000 claims description 20
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 9
- 230000006870 function Effects 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 239000001301 oxygen Substances 0.000 claims description 9
- 238000004458 analytical method Methods 0.000 claims description 6
- 238000004891 communication Methods 0.000 claims description 6
- 230000003287 optical effect Effects 0.000 claims description 4
- 238000011161 development Methods 0.000 claims description 3
- 238000009532 heart rate measurement Methods 0.000 claims description 3
- 210000000265 leukocyte Anatomy 0.000 claims 2
- 208000035473 Communicable disease Diseases 0.000 abstract description 2
- 230000005856 abnormality Effects 0.000 abstract 1
- 238000010420 art technique Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 description 22
- 239000000523 sample Substances 0.000 description 14
- 208000015181 infectious disease Diseases 0.000 description 11
- 238000012544 monitoring process Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 241000711573 Coronaviridae Species 0.000 description 10
- 241000700605 Viruses Species 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 241001678559 COVID-19 virus Species 0.000 description 9
- 238000003745 diagnosis Methods 0.000 description 9
- 239000003550 marker Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 5
- 238000003908 quality control method Methods 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 239000002351 wastewater Substances 0.000 description 5
- 206010036790 Productive cough Diseases 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 208000024794 sputum Diseases 0.000 description 4
- 210000003802 sputum Anatomy 0.000 description 4
- 108010033276 Peptide Fragments Proteins 0.000 description 3
- 102000007079 Peptide Fragments Human genes 0.000 description 3
- 229940096437 Protein S Drugs 0.000 description 3
- 108020004518 RNA Probes Proteins 0.000 description 3
- 238000002123 RNA extraction Methods 0.000 description 3
- 239000003391 RNA probe Substances 0.000 description 3
- 101710198474 Spike protein Proteins 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 206010035664 Pneumonia Diseases 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000013473 artificial intelligence Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000002484 cyclic voltammetry Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000012806 monitoring device Methods 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 208000004672 Cardiovascular Infections Diseases 0.000 description 1
- 102100031673 Corneodesmosin Human genes 0.000 description 1
- 101710139375 Corneodesmosin Proteins 0.000 description 1
- 208000001528 Coronaviridae Infections Diseases 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241001112090 Pseudovirus Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008476 aike Substances 0.000 description 1
- 230000002788 anti-peptide Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 238000013100 final test Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 238000011330 nucleic acid test Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Y—INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR THE INTERNET OF THINGS [IoT]
- G16Y40/00—IoT characterised by the purpose of the information processing
- G16Y40/20—Analytics; Diagnosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02438—Detecting, measuring or recording pulse rate or heart rate with portable devices, e.g. worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Y—INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR THE INTERNET OF THINGS [IoT]
- G16Y10/00—Economic sectors
- G16Y10/60—Healthcare; Welfare
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Y—INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR THE INTERNET OF THINGS [IoT]
- G16Y20/00—Information sensed or collected by the things
- G16Y20/40—Information sensed or collected by the things relating to personal data, e.g. biometric data, records or preferences
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Computing Systems (AREA)
- Optics & Photonics (AREA)
- Physiology (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Economics (AREA)
- Accounting & Taxation (AREA)
- Development Economics (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Bioethics (AREA)
- Computer Networks & Wireless Communication (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Pulmonology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
INTELLIGENT CIRCUIT ENABLE COVID-19
DETECTION FRAMEWORK USING IOT
ABSTRACT
The present invention is related to intelligent circuit enable
covid-19 detection framework using IOT. The objective of present
invention is to solve the abnormalities presented in the prior art
techniques related to detection for the infectious diseases like Covid-19
using IOT.
29
icants: Dr. Samarendra Dash& others Sheet 1 of Total Sheet 1
Temperature
Multi Internet of Things Central ControlUnit
Sensor Unit
COVID
Detection
FIGURE 1
30
Description
icants: Dr. Samarendra Dash& others Sheet 1 of Total Sheet 1
Temperature
Multi Internet of Things Central ControlUnit
Sensor Unit
COVID Detection
FIGURE 1
INTELLIGENT CIRCUIT ENABLE COVID-19
[001]. The present invention relates to the technical field of diagnose
of infectious disease.
[002]. Particularly, the present invention relates to testing of person for
Covid-19 using sensor.
[003]. The present invention relates to the field of sensor and processor
based detection of covid for a person using.
[004]. More particularly, the present invention is related to intelligent
circuit enable covid-19 detection framework using IOT.
[005]. The subject matter discussed in the background section should
not be assumed to be prior art merely as a result of its mention in the background section. Similarly, a problem mentioned in the background section or associated with the subject matter of the background section should not be assumed to have been previously recognized in the prior art. The subject matter in the background section merely represents different approaches, which in-and-of themselves may also be inventions.
[006]. Since December 2019, a movement of patients with dark
explanation pneumonia had been represented in Wuhan, Hubei space
of China. WHO on March 11, 2020, proclaimed
[007]. Corona virus infection as a general wellbeing crisis and a
pandemic internationally, the most extreme contaminated people
were distinguished as guys who had unfavorable medical issue like
hypertension, cardiovascular infections and diabetes. Fever, hack,
windedness and weakness are the most ordinarily noticed side effects
in this COVID-19 infection.
[008]. The transmission of the infection is seen to happen through
direct contact with the contaminated individual or nearby other
people with them. The disengagement of the infection on January 7,
2020, lead to the commencement in the improvement of demonstrative instruments that are profoundly exact, solid, reduced and exceptionally touchy.
[009]. Consequently, absolutely determine the patients asserted to have
SARS-CoV-19 disease for the chance to segregate the infection and
the treatment of the patients. The broadly utilized test for diagnosing
SARS-CoV-19 as of now for example switch record quantitative
polymerase chain response examine which includes enhancement of
viral RNA from the example gathered from the analyzed patient.
[0010]. As announced in a few articles, the recovery of an example from
the lower respiratory plot has caused uneasiness and in specific cases
draining in the patients. It likewise puts medical services experts in
danger of transmission of the COVID-19 infection. In any case, this
RT-PCR strategy has certain downsides like the absence of
continuous observing, long preparing time along prepared staff for
working progressed research facility gear. Hence, researchers and
specialists all around the world are occupied with creating simpler
and less expensive constant symptomatic instruments for the
recognition of the COVID-19 infection. As of late, biosensors have
acquired impossible consideration in the clinical field particularly in
the determination of different viral and bacterial illnesses.
[0011]. Biosensors can be all around used in regions like medication
recognition, food quality administration and symptomatic of
sicknesses. In this work, we propose a multifunctional sensor that
directs various estimations of different boundaries needed for the
identification of the COVID-19 infection.
[0012]. Some of prior work is listed herewith:
[0013]. 20200340945ELECTROCHEMICAL APPROACH FOR
COVID-19 DETECTION US - 29.10.2020 Int.Class GOIN
27/327Appl.No 16924718Applicant Mohammad AbdolahadInventor
Mohammad Abdolahad A method for diagnosing COVID-19
infection of a person. The method includes acquiring a sputum
sample of a person, measuring a level of ROS in the sputum sample,
and detecting a COVID-19 infection status of the person based on
the measured level of ROS. Measuring the level of ROS in the
sputum sample includes recording a cyclic voltammetry (CV) pattern
from the sputum sample and measuring a current peak of the
recorded CV pattern. Detecting the COVID-19 infection status of the
person includes detecting COVID-19 infection of the person
responsive to the measured current peak being in a first range of
more than 230 A and detecting COVID-19 non-infection of the person responsive to the measured current peak being in a second range of less than 190 pA.
[0014]. 111398581COVID-19 RAPID DIAGNOSIS KIT AND
PREPARATION METHOD THEREOF CN - 10.07.2020 Int.Class
GOIN 33/569Appl.No 202010126276.XApplicant SICHUAN
PROVINCIAL PEOPLE'S OSPITALInventor YANG ZHENGLIN
The invention discloses a COVID-19 rapid diagnosis kit. The
COVID-19 rapid diagnosis kit comprises COVID-19 spike protein
antigen colloidal gold. The invention also discloses a preparation
method of the COVID-19 rapid diagnosis kit. The preparation
method comprises the following steps: expressing and purifying
COVID-19 spike protein; and preparing the COVID-19 spike protein
antigen colloidal gold.The kit is simple to operate, can quickly
diagnose whether a patient is infected with COVID-19 or not, and is
beneficial to effective control of epidemic situations.
[0015]. 3871TELEMETRY MONITORING SYSTEM FOR
PATIENTS DIAGNOSED WITH COVID-19 BG - 15.09.2020
Int.Class A61B 5/OOAppl.No 50642OApplicant BEST MEDIKAL
KEAR OODInventor STOIMENOV BLAGOVEST This utility
model relates to a system for telemetry monitoring of patients diagnosed with COVID-19, which will find application in the field of healthcare, in particular in the systematic monitoring of patients treated at home by COVID-19. The designed telemetry monitoring system for patients diagnosed with COVID-19 comprises a telemetry monitoring device (1), a manual X-ray camera (2) and a PCR test machine (3). The telemetry monitoring device (1) is connected to a computer with a monitor (4). The manual X-ray camera (2) is connected to a module with installed artificial intelligence (5). The
PCR test machine (3) and the computer with monitor (4) are
unidirectionally connected to a computer with installed software for
processing statistical data and analysis (6), to which bidirectionally
is connected also the module with installed artificial intelligence (5).
[0016]. 202041030100DESIGN AND DEVELOPMENT OF COVID
19 DIAGNOSTIC SYSTEM IN - 07.08.2020 Int.Class A61B
5/00Appl.No 202041030100Applicant PROF. RAVI KUMAR
PULlInventor AASHRAY RAJ MATHUR Covid-19 Diagnostic
System is a system that can detect likelihood of the respiratory
diseases (if any) like Covid-19 (i.e. pneumonia like symptoms) etc,
measure oxygen saturation and temperature of the patient. A Covid
19 Diagnostic System includes a testing stand which comprises of stethoscopes connected to a microphone to listen and record the respiratory sounds of the patient, a pulse oximeter to measure the oxygen saturation level of the patient, an IR temperature sensor to measure the temperature of the patient, two OLED displays to display the real-time results of oxygen saturation and temperature of the patient, buzzer to beep in case of abnormal readings and a computer which comprises of a machine learning software i.e.
Covid-19 Diagnostic Management System to combine and analyse
all readings from the three parameters to produce the final test result.
[0017]. 111647685PRIMER SET, PROBE SET AND KIT FOR
DETECTING COVID-19 VIRUS, AND APPLICATION OF KIT
CN - 11.09.2020 Int.Class C12Q 1/70Appl.No
202010425877.OApplicant GUANGZHOU ZHONGKE
ANTIBODY BIOTECHNOLOGY CO., LTD.Inventor ZHOU
NING The invention discloses a primer set for detecting the COVID
19 virus. The primer set comprises an upstream primer and a
downstream primer, and the primer set has relatively low sample
requirements and strong amplification specificity, and greatly
improves the sensitivity of clinical detection results. The invention
also discloses a probe set for detecting the COVID-19 virus. The probe set comprises a first probe and a second probe, and the probes can bind to target single-stranded DNA by base complementary pairing respectively, and are captured by magnetic beads, so that the purpose of amplifying optical signals and performing quantitative detection is realized. The invention also discloses a kit for detecting the COVID-19 virus. The kit uses the primer set and the probe set, combines with the magnetic bead capture and optical signal amplification technology, has the characteristics of high sensitivity and high specificity, has simple operation, has low cost, and can be widely used inprimary medical institutions. The kit can be used to detect the COVID-19 virus, has stable and reliable detection results, has wide applicable scenarios, and has great market prospects.
[0018]. 202011020968A KIT FOR RNA EXTRACTION TO DETECT
COVID-19 BY RT-Q PCR AND METHODS THEREOF IN
26.06.2020 Int.Class C12Q /Appl.No 202011020968Applicant All
India Institute of Medical Sciences (AIIMS), JodhpurInventor Dr.
Ravisekhar Gadepalli Discloses herein a kit for RNA extraction to
detect COVID-19 by RT-q PCR. The present invention also relates
to a Unique, Rapid and affordable COVID-19 diagnostics method
which could help to limit the spread of SARS-CoV-2, potentially saving many of lives, but RNA extraction constitutes a barrier to scale-up of testing. The procedure could be especially useful for massively scaling up SARS-CoV-2 testing, as the logistics and cost of RNA purification could be unworkable in mass testing.
Importantly, the direct method is also attractive in settings where
repeated, cheaper, and quicker testing is desirable, for example in
frequent testing of healthcare personnel. This study will help in
establishment of rapid and confirmed diagnosis of COVID-19
enabling early and proper treatment and control measures. The
present invention reduces the time of testing by RT-PCR from 8hrs
(Conventional Method) and to 4hrs not using any Kit or RNA
extractor.
[0019]. 111978377COVID-19 ANTIGEN, PREPARATION METHOD
AND APPLICATION CN - 24.11.2020 Int.Class C07K
14/165Appl.No 202010657369.5Applicant SUZHOU HERUI
BIOTECHNOLOGY CO., LTD.Inventor CHEN FEI The invention
discloses an important epitope SEQ ID:01 and SEQ ID:02 for
detecting a COVID-19 antibody, and a recombinant protein
containing the antigen epitope can be used for the preparation of
anti-COVID-19 antibody detection such as IgM and IgG. The anti
COVID-19 antibody detection reagent is an effective supplement to
the COVID-19 nucleic acid test and can be used to screen contacts of
the COVID-19 and people with immunity. The invention overcomes
the problems of insufficient single S protein epitope, insufficient
detection sensitivity of anti-COVID-19 IgM antibody and the like.
The anti-COVID-19 antibody detection reagent prepared from the
recombinant protein containing SEQ01-04 new epitopes has the
advantages of high sensitivity, stable performance, qualitative
accuracy and the like.
[0020]. 111748654RNA PROBE FOR DETECTING COVID-2019
APPLICATION OF RNA PROBE CN - 09.10.2020 Int.Class C12Q
1/70Appl.No 202010790666.7Applicant HUNAN NORMAL
UNIVERSITYInventor XIE HUAPING The invention discloses an
RNA probe for detecting covid-2019 coronavirus as well as a
preparation method and an application of the RNA probe, which
belongs to the technical field of nucleic acid hybridization. The
nucleotide sequence of the RNA probe is shown as SEQ ID No.l.
The preparation process comprises the following steps: designing
primers, constructing recombinant plasmids, carrying out PCR amplification and carrying out in-vitro transcription. The prepared probe is applied to detection of covid-2019, covid-2019 virus nucleic acid can be detected at the single cell level, and the detection sensitivity, accuracy and specificity are improved.
[0021]. 20214100522810T WITH Al POWERED COVID-19
DETECTION ON MASSES IN - 19.02.2021 Int.Class A61B
/ Appl.No 202141005228 Applicant Dr. N. GOMATHI Inventor Dr.
N. GOMATHI ABSTRACT IOT WITH Al POWERED COVID-19
DETECTION ON MASSESThe present invention relates to loT with
Al powered covid -19 detection on masses . Current health crisis
around the world, healthcare fields often choose to opt for new
technological innovation for detection and diagnosis of covid-19
infections. Al technology is one such effective way that can track the
virus spread and the risk of infections in real-time environment.
However monitoring individuals is a difficult task since the Al
powered engine has to undergo lot more changes as its gets abundant
input request from the loT sensors. In order to cope up with the
current crisis and to enable faster processing by Al engines, the
proposal enables IoT powered pulse oximeter and an IoT powered
temperature sensor for data acquisition from an individual and transmits the data to nearby Al power processing engine to detect whether an individual is infected with Covid-19 or not. Both the IoT sensors will be integrated with cellphone cases such that it will enable easier transportation by the individuals. Such integrated module connected with Al powered'mobile application will process the condition of the person and sends the report to local government authorities or nearby hospitals. Such mechanism enabled the real time tracking of individuals and reduces the spread of infection.
[0022]. 0002743687METHOD OF MONITORING COVID-19
RU - 24.02.2021 Int.Class GOIN 33/569 Appl.No 2020140957
Applicant Inventor FaJIHIKaHflOJMHa IOpbeBHa (RU) FIELD:
virology. SUBSTANCE: invention relates to the field of virology.
Disclosed is a method for monitoring COVID-19 morbidity.
According to the method, it's necessary to determine a correction
factor (m) representing a lower limit for determining the morbidity
rate and monitoring COVID-19 morbidity. To determine m, aliquots
of fecal samples of patients with a confirmed diagnosis of COVID
19 are taken and diluted with model wastewater to obtain samplesX2
1 .... No p. Samples N2 1 .... No p undergo a serial dilution until the lower limit of determination of the real-time RT-PCR method is reached. After that the arithmetic mean value of the maximum degrees of dilution is averaged and calculated. The correction factor m is defined as the ratio of 100 to the arithmetic mean. RNA is isolated from wastewater samples with the purpose of monitoring.
The samples are analyzed for the presence of SARS-CoV-2 viral
particles. If the result is negative, the morbidity rate is 0%. If the
result is positive, serial dilutions of wastewater samples are prepared
until the lower limit of determination of the real-time RT-PCR
method is reached. After that the maximum degree of dilution of
wastewater (k) is determined. The value of the morbidity rate of
COVID-19 (N,%) is calculated in accordance with the formula N = k
* m. EFFECT: improved accuracy of results and reduced duration of
sample analysis. 1 cl, 2 ex, 5 dwg
[0023]. 111999508DIAGNOSTIC MARKER AND APPLICATION
THEREOF IN COVID-19 DIAGNOSIS AND CORONAVIRUS
PREVIOUS INFECTION DETECTION CN - 27.11.2020 Int.Class
GOIN 33/68 Appl.No 202011022224.4 Applicant SHANGHAI
JIAO TONG UNIVERSITY Inventor TAO SHENGCE The
invention discloses a diagnostic marker and application of the diagnostic marker in COVID-19 diagnosis and coronavirus previous infection detection. The diagnostic marker comprises a peptide fragment COVID-19-V001, the amino acid sequence of the peptide fragment COVID-19-VOO1is a sequence containing five or more continuous amino acids in FKEELDKYFKNH, or the amino acid sequence of the peptide fragment COVID-19-VOO1 is a sequence formed by substituting or/and deleting or/and adding one or more amino acids in FKEELDKYFKNH. Based on the diagnostic marker provided by the invention, an indirect method is adopted to qualitatively detect the level of the IgG antibody of the anti-peptide fragment in human serum. A detection kit established on the basis of the diagnostic marker can be used as anauxiliary means for diagnosing the coronavirus disease 2019 (COVID-19).
[0024]. 2020101728SMART COVID SCANNER: PORTABLE AND
AFFORDABLE SCANNER TO DETECT COVID-19 VIRUS AU
27.08.2020 Int.Class A61B 5/00 Appl.No 2020101728 Applicant
Balusamy, Balamurugan PROF Inventor The world is facing the
situation of an outbreak of the most recent corona virus called
COVID-19 that has impacted the entire humanity. So scientists and
researchers from diverse backgrounds are continuously working together to fight against this very new type of virus. So there's an urgent need for preventive equipment like sanitizers, masks to prevent individuals from getting infected, as prevention is the only available cure for now. Apart from this, the technology can also help to fight against COVID-19 as nowadays advanced technologies are being used as a critical component in these types of scenarios. The proposed solution is a portable scanner that can detect the COVID
19 virus over any surface or person & warn the user prior to its
spreading. The scanner works with micro bio scanner that
captures/detects the virus just like electron microscope emits rays for
detection of microorganism, in the same way, this bio scanner which
is integrated with Al-based system detects the COVID particles and
classifies the virus based on the past training about the texture, size,
and shape of COVID droplets. This scanner can be a great tool
against COVID-19 and can be used in a wide range of applications
so as to prevent the further spreading of this deadly virus. Smart
COVID Scanner: Portable and affordable scanner to detect COVID
19 virus Diagram Fig 1: Smart COVID Scanner
[0025]. 112029899NOVEL CORONAVIRUS RNA NUCLEIC ACID
PREPARATION METHOD THEREOF CN - 04.12.2020 Int.Class
C12Q 1/70 Appl.No 202010262726.8 Applicant SUZHOU AIKE
RUISI BIOTECHNOLOGY CO., LTD. Inventor YUAN JIAYANG
The invention provides a novel coronavirus RNA nucleic acid
detection quality control product, which is used for comprehensively
monitoring a COVID-19 nucleic acid detection process. The general
preparation process of the novel coronavirus RNA nucleic acid
detection quality control product comprises the following steps: 1)
integrating COVID-19 ORFlab and N gene fragments and
performing plasmid amplification; 2) amplifying an expression
system of modified phage; 3) expressing, purifying and identifying
pseudovirus particles; and 4) performing quantitative detection and
subpackaging. The novel coronavirus RNA nucleic acid detection
quality control product provided by the invention has structural
consistency with actual COVID-19 virus particles, and can truly
simulate the in-vitro nucleic acid detection process of the COVID-19
virus particles, thereby realizing comprehensive monitoring of
COVID-19 nucleic acid detection; and the product has the
advantages of low cost, high stability, convenience in storage and
transportation and the like, and is convenient for industrial-level
large-scale production. In conclusion, the novel coronavirus RNA nucleic acid detection quality control product provided by the invention has important value and application prospects.
[0026]. ... Groupings of alternative elements or embodiments of the invention
disclosed herein are not to be construed as limitations. Each group member
can be referred to and claimed individually or in any combination with
other members of the group or other elements found herein. One or more
members of a group can be included in,
[0027]. or deleted from, a group for reasons of convenience and/or
patentability. When any such inclusion or deletion occurs, the specification
is herein deemed to contain the group as modified thus fulfilling the written
description of all Markus groups used in the appended claims.
[0028]. As used in the description herein and throughout the claims that
follow, the meaning of "a," "an," and "the" includes plural reference
unless the context clearly dictates otherwise. Also, as used in the
description herein, the meaning of "in" includes "in" and "on" unless
the context clearly dictates otherwise.
[0029]. The recitation of ranges of values herein is merely intended to
serve as a shorthand method of referring individually to each separate
value falling within the range. Unless otherwise indicated herein, each
individual value is incorporated into the specification as if it were
individually recited herein. All methods described herein can be
performed in any suitable order unless otherwise indicated herein or
otherwise clearly contradicted by context.
[0030]. The use of any and all examples, or exemplary language (e.g.
"such as") provided with respect to certain embodiments herein is
intended merely to better illuminate the invention and does not pose a
limitation on the scope of the invention otherwise claimed. No
language in the specification should be construed as indicating any
non-claimed element essential to the practice of the invention.
[oo31]. The above information disclosed in this Background section is
only for enhancement of understanding of the background of the
invention and therefore it may contain information that does not form
the prior art that is already known in this country to a person of
ordinary skill in the art.
[0032]. The present invention mainly cures and solves the technical
problems existing in the prior art. In response to these problems, the
present invention provides intelligent circuit enable covid-19 detection
framework using IOT.
[0033]. As one aspect of the present invention relates to A system of
Intelligent Circuit Enable Covid-19 Detection Framework Using IOT
A multi functions internet of thing sensor unit, used to use to measure
various physical and biomedical parameter of the human body,
wherein the multi functions internet of thing sensor unit Comprises:
An oxygen sensing unit, used to sense oxygen level of the patient, A
communication unit, used to communicate the information external
device; A pulse measurement unit, used to measure pulse rate of the
patient; and A Center control processing unit, center control processing unit is used Store the medical data and continuously monitor the patient with biomedical parameter, wherein system send the communication signal to the center control processing unit, wherein the center control processing unit display the different biomedical signal on the a display device , and control by the medical practitioner , wherein the medical practitioner can set a limit of different biomedical signal to generate an alarm signal.
[0034]. The principle objective of the present invention is to provide
intelligent circuit enable covid-19 detection framework using IOT.
[0035]. Further clarify various aspects of some example embodiments of
the present invention, a more particular description of the invention
will be rendered by reference to specific embodiments thereof which
are illustrated in the appended drawings. It is appreciated that these
drawings depict only illustrated embodiments of the invention and are
therefore not to be considered limiting of its scope. The invention will
be described and explained with additional specificity and detail
through the use of the accompanying drawings.
[0036]. In order that the advantages of the present invention will be
easily understood, a detailed description of the invention is discussed
below in conjunction with the appended drawings, which, however,
should not be considered to limit the scope of the invention to the
accompanying drawings, in which:
[0037]. Figure 1 shows an exemplary representation of intelligent circuit
enable covid-19 detection framework using IOT, according to the
present invention.
[0038]. The present invention discloses intelligent circuit enable covid
19 detection framework using IOT.
[0039]. Figure 1 shows the exemplary representation of intelligent
circuit enable covid-19 detection framework using IOT, according to
the present invention.
[0040]. Although the present disclosure has been described with the
purpose of two intelligent circuit enable covid-19 detection framework
using IOT, it should be appreciated that the same has been done
merely to illustrate the invention in an exemplary manner and to
highlight any other purpose or function for which explained structures
or configurations could be used and is covered within the scope of the
present disclosure.
[0041]. A system of Intelligent Circuit Enable Covid-19 Detection
Framework Using IOT is disclosed.
[0042]. The system comprises a multi functions internet of thing sensor
unit, used to use to measure various physical and biomedical
parameter of the human body.
[0043]. The multi functions internet of thing sensor unit Comprises an
oxygen sensing unit, used to sense oxygen level of the patient.
[0044]. A communication unit, used to communicate the information
external device;
[0045]. A pulse measurement unit is used to measure pulse rate of the
patient.
[0046]. A Center control processing unit is used Store the medical data
and continuously monitor the patient with biomedical parameter.
[0047]. The system sends the communication signal to the center control
processing unit.
[0048]. The center control processing unit display the different
biomedical signal on a display device, and control by the medical
practitioner, wherein the medical practitioner can set a limit of
different biomedical signal to generate an alarm signal.
[0049]. The multi functions internet of thing sensor unit comprises a
LM35 internet of thing sensor series and optical internet of thing
sensor has used along with development implementation done for
getting the temperature and for quantitatively analyses the white
blood cell (WBC)
[0050]. The Center control processing unit is microcontroller based
Center control processing unit.
[0051]. A display is used to display the output after processing of the
information.
[0052]. The present invention is low weight and portable where anyone
can travel with this and can be relocate without any problem.
[0053]. The figures and the foregoing description give examples of
embodiments. Those skilled in the art will appreciate that one or
more of the described elements may well be combined into a single
functional element. Alternatively, certain elements may be split into
multiple functional elements.
[0054]. Elements from one embodiment may be added to another
embodiment. For example, order of processes described herein may
be changed and are not limited to the manner described herein.
[0055]. Moreover, the actions of any block diagram need not be
implemented in the order shown; nor do all of the acts need to be
necessarily performed. Also, those acts that are not dependent on
other acts may be performed in parallel with the other acts. The
scope of embodiments is by no means limited by these specific
examples.
[0056]. Although implementations of the invention have been described
in a language specific to structural features and/or methods, it is to
be understood that the appended claims are not necessarily limited to
the specific features or methods described. Rather, the specific
features and methods are disclosed as examples of implementations
of the invention.
Claims (5)
1. A system of Intelligent Circuit Enable Covid-19 Detection
Framework Using IOT, wherein the system comprises:
A multi functions internet of thing sensor unit, used to use to
measure various physical and biomedical parameter of the
human body, wherein the multi functions internet of thing
sensor unit Comprises:
An oxygen sensing unit, used to sense oxygen level of the
patient,
A communication unit, used to communicate the information
external device;
A pulse measurement unit, used to measure pulse rate of the
patient; and
A Center control processing unit, center control processing
unit is used Store the medical data and continuously monitor
the patient with biomedical parameter, wherein system send
the communication signal to the center control processing unit, wherein the center control processing unit display the different biomedical signal on the a display device , and control by the medical practitioner , wherein the medical practitioner can set a limit of different biomedical signal to generate an alarm signal.
2. The system of Intelligent Circuit Enable Covid-19 Detection
Framework Using IOT as claimed in claim 1, wherein the multi
functions internet of thing sensor unit comprises a LM35
internet of thing sensor series and optical internet of thing sensor
has used along with development implementation done for
getting the temperature and for quantitatively analyse the white
blood cell (WBC).
3. The system of Intelligent Circuit Enable Covid-19 Detection
Framework Using IOT as claimed in claim 1, The Center
control processing unit is microcontroller based Center control
processing unit.
4. The system of Intelligent Circuit Enable Covid-19 Detection
Framework Using IOT as claimed in claim 1, A display is used
to display the output after processing of the information.
5. The system of Intelligent Circuit Enable Covid-19 Detection
Framework Using IOT as claimed in claim 1, the present
invention is low weight and portable where anyone can travel
with this and can be relocate without any problem.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021104943A AU2021104943A4 (en) | 2021-08-04 | 2021-08-04 | Intelligent circuit enable covid-19 detection framework using iot |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021104943A AU2021104943A4 (en) | 2021-08-04 | 2021-08-04 | Intelligent circuit enable covid-19 detection framework using iot |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2021104943A4 true AU2021104943A4 (en) | 2022-04-14 |
Family
ID=81079632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021104943A Ceased AU2021104943A4 (en) | 2021-08-04 | 2021-08-04 | Intelligent circuit enable covid-19 detection framework using iot |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2021104943A4 (en) |
-
2021
- 2021-08-04 AU AU2021104943A patent/AU2021104943A4/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kim et al. | A serosurvey of Orientia tsutsugamushi from patients with scrub typhus | |
| Higuchi et al. | Relationship between whole-blood interferon-gamma responses and the risk of active tuberculosis | |
| Kaushik et al. | To manage long COVID by selective SARS-CoV-2 infection biosensing | |
| Brief | Emergence of SARS-CoV-2 B. 1.617 variants in India and situation in the EU/EEA | |
| Zeng et al. | Monocyte volumetric parameters and lymph index are increased in SARS‐CoV‐2 infection | |
| Rodríguez-Aguilar et al. | Comparative analysis of chemical breath-prints through olfactory technology for the discrimination between SARS-CoV-2 infected patients and controls | |
| Ai et al. | Clinical value of interferon‑γ release assay in the diagnosis of active tuberculosis | |
| CN102841199A (en) | Method for rapidly diagnosing flu | |
| Ali et al. | Assessment of cell free mitochondrial DNA as a biomarker of disease severity in different viral infections | |
| AU2021104943A4 (en) | Intelligent circuit enable covid-19 detection framework using iot | |
| Sant’Anna et al. | Diagnosis of tuberculosis among children and adolescents | |
| Song et al. | Early and consecutive RT-PCR tests with both oropharyngeal swabs and sputum could improve testing yield for patients with COVID-19: An observation cohort study in China | |
| CN103675293B (en) | The purposes of Rv3872, Rv0164 and/or Rv1926c albumen in the phthisical product of preparation diagnostic activities | |
| CN103698530B (en) | The purposes of Mycobacterium tuberculosis albumen in the phthisical product of preparation diagnostic activities | |
| Bhattacherjee et al. | COVID‐19 Diagnostics: Current Approach, Challenges, and Technology Adaptation | |
| Pérez et al. | A simple algorithm for the diagnosis of AIDS-associated genitourinary tuberculosis | |
| WO2021213291A1 (en) | Hematological parameter for viral infection | |
| Jung et al. | Comparison of human interpretation and a rule-based algorithm for instrumented sit-to-stand test | |
| Thorat et al. | Volatile Organic Compounds as a Biomarker of Tuberculosis | |
| CN103675292B (en) | The purposes of Rv0174, Rv1729c and/or Rv3835 albumen in the phthisical product of preparation diagnostic activities | |
| Zhang et al. | Clinical Features and Detection Methods of Covid-19 Asymptomatic Patients | |
| Abdalruda et al. | The Association of IgM and IgG with severity of coronavirus disease in Iraqi population | |
| CN212724739U (en) | System for evaluating infection possibility of new coronary pneumonia | |
| AL Hadraawy et al. | Estimate of immunoglobulin G, M, and some liver enzymes levels in Covid-19 patients and relation with blood group in Najaf governorate, Iraq | |
| CN106520916A (en) | Applications of lncRNA-MIR3945HG V2 in diagnosis of mycobacterium tuberculosis negative pulmonary tuberculosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGI | Letters patent sealed or granted (innovation patent) | ||
| MK22 | Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry |